- Q1 2024 Zymeworks Inc Earnings Call TranscriptMay 02, 2024$9 (+2.74%)Earnings
- Q4 2023 Zymeworks Inc Earnings Call TranscriptMar 06, 2024$12.23 (+2.09%)Earnings
- Zymeworks Inc at Citi Virtual Oncology Leadership Summit TranscriptFeb 22, 2024
- Zymeworks Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Zymeworks Inc Earnings Call TranscriptNov 07, 2023$7.37 (+1.24%)Earnings
- Zymeworks Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Zymeworks Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Zymeworks Inc Earnings Call TranscriptAug 10, 2023$7.76 (+0.78%)Earnings
- Zymeworks Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Zymeworks Inc Earnings Call TranscriptMay 08, 2023$8.76 (+1.39%)Earnings
- Zymeworks Inc Investor Call TranscriptApr 18, 2023
- Zymeworks Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Zymeworks Inc Earnings Call TranscriptMar 07, 2023$7.96 (+0.13%)Earnings
- Zymeworks Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Zymeworks Inc HERIZON-BTC-01 Top-Line Results Call TranscriptDec 19, 2022
Zymeworks Inc HERIZON-BTC-01 Top-Line Results Call Transcript
Thank you for standing by. This is the conference operator. Welcome to Zymeworks HERIZON-BTC-01 Webcasting Conference Call.
(Operator Instructions)
I would now like to turn the conference over to Kenneth Galbraith, Chair and CEO at Zymeworks. Ken, please go ahead.
Thank you. Hello, everyone, and thanks for joining. My name is Ken Galbraith. I'm the Chair and CEO at Zymeworks. I want to take the time with you today to discuss the positive top-line results for our HERIZON-BTC-01 study. In short order, I'll hand the call over to Dr. Neil Josephson, our Chief Medical Officer as well as Dr. Shubham Pant, who has experience treating patients with zanidatamab in our Phase I and pivotal trials and is also Chairman of the Steering Committee for the HERIZON-BTC-01 study.
All 3 of us will be available for Q&A after the call. Before we begin, I'd like to remind you we'll be making forward-looking statements during this call. Forward-looking statements can be identified
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)